White coat hypertension: Improving the patient–health care practitioner relationship

Psychology Research and Behavior Management

Volumn 8, Issue , 2015, Pages 133-141

  Cobos, Briana ^a   Haskard Zolnierek, Kelly ^a   Howard, Krista ^a  

^a TEXAS STATE UNIVERSITY   (United States)

Author keywords

Anxiety; Health care professional patient relationship; Physician patient communication; White coat hypertension

Indexed keywords

EID: 84930942242     PISSN: None     EISSN: 11791578     Source Type: Journal    
DOI: 10.2147/PRBM.S61192     Document Type: Review

References (73)

1. Celis H, Fagard RH. White-coat hypertension: a clinical review. Eur J Intern Med. 2004;15(6):348–357.
2. Mancia G, Bombelli M, Seravalle G, Grassi G. Diagnosis and management of patients with white-coat and masked hypertension. Nat Rev Cardiol. 2011;8(12):686–693.
3. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159–2219.
4. Sipahioglu NT, Sipahioglu F. Closer look at white-coat hypertension. World J Methodol. 2014;4(3):144–150.
5. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–520.
6. Dolan E, Stanton A, Atkins N, et al. Determinants of white-coat hypertension. Blood Press Monit. 2004;9(6):307–309.
7. Franklin SS, Thijs L, Hansen TW, O’Brien E, Staessen JA. White-coat hypertension: new insights from recent studies. Hypertension. 2013; 62(6):982–987.
8. Boggia J, Hansen T, Asayama K, Luzardo L, Li Y, Staessen J. White-coat Hypertension on Automated Blood Pressure Measurement Implications for Clinical Practice. Eur J Cardiovasc Med. 2011;1:17–21.
9. Grossman E. Ambulatory blood pressure monitoring in the diagnosis and management of hypertension. Diabetes Care. 2013;36(Suppl 2): S307–S311.
10. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005;111(5):697–716.
11. Myers MG, Valdivieso MA. Use of an automated blood pressure recording device, the BpTRU, to reduce the “white coat effect” in routine practice. Am J Hypertens. 2003;16(6):494–497.
12. Muxfeldt ES, Bloch KV, Nogueira AR, Salles GF. True resistant hypertension: is it possible to be recognized in the office? Am J Hypertens. 2005;18(12 Pt 1):1534–1540.
13. Cohen DL, Townsend RR. How significant is white coat hypertension? J Clin Hypertens (Greenwich). 2010;12(8):625–626.
14. Fisher M, Blackwell J, Saseen J. What is the best way to identify patients with white-coat hypertension? J Fam Pract. 2005;54(6): 549–550
15. Verdecchia P, Palatini P, Schillaci G, Mormino P, Porcellati C, Pessina AC. Independent predictors of isolated clinic (‘white-coat’) hypertension. J Hypertens. 2001;19(6):1015–1020.
16. Manios ED, Koroboki EA, Tsivgoulis GK, et al. Factors influencing white-coat effect. Am J Hypertens. 2008;21(2):153–158.
17. MacDonald MB, Laing GP, Wilson MP, Wilson TW. Prevalence and predictors of white-coat response in patients with treated hypertension. CMAJ. 1999;161(3):265–269.
18. Mancia G, Bertinieri G, Grassi G, et al. Effects of blood-pressure measurement by the doctor on patient’s blood pressure and heart rate. Lancet. 1983;2(8352):695–698.
19. Grassi G, Turri C, Vailati S, Dell’Oro R, Mancia G. Muscle and skin sympathetic nerve traffic during the “white-coat” effect. Circulation. 1999;100(3):222–225.
20. Ogedegbe G, Pickering TG, Clemow L, et al. The misdiagnosis of hypertension: the role of patient anxiety. Arch Intern Med. 2008; 168(22):2459–2465.
21. Parati G, Pomidossi G, Casadei R, et al. Comparison of the cardiovascular effects of different laboratory stressors and their relationship with blood pressure variability. J Hypertens. 1988;6(6):481–488.
22. Gerin W, Marion RM, Friedman R, James GD, Bovbjerg DH, Pickering TG. How should we measure blood pressure in the doctor’s office? Blood Press Monit. 2001;6(5):257–262.
23. Jhalani J, Goyal T, Clemow L, Schwartz JE, Pickering TG, Gerin W. Anxiety and outcome expectations predict the white-coat effect. Blood Press Monit. 2005;10(6):317–319.
24. Spruill TM, Pickering TG, Schwartz JE, et al. The impact of perceived hypertension status on anxiety and the white coat effect. Ann Behav Med. 2007;34(1):1–9.
25. Helvaci MR, Sevinc A, Camci C, Yalcin A. Treatment of white coat hypertension with metformin. Int Heart J. 2008;49(6):671–679.
26. Alberti KG, Eckel RH, Grundy SM, et al; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–1645.
27. Björklund K, Lind L, Vessby B, Andrén B, Lithell H. Different metabolic predictors of white-coat and sustained hypertension over a 20-year follow-up period: a population-based study of elderly men. Circulation. 2002;106(1):63–68.
28. Hosaka M, Mimura A, Asayama K, et al. Relationship of dysregulation of glucose metabolism with white-coat hypertension: the Ohasama study. Hypertens Res. 2010;33(9):937–943.
29. Martin CA, McGrath BP. White-coat hypertension. Clin Exp Pharmacol Physiol. 2014;41(1):22–29.
30. Mancia G, Bombelli M, Facchetti R, et al. Long-term risk of sustained hypertension in white-coat or masked hypertension. Hypertension. 2009;54(2):226–232.
31. Glen SK, Elliott HL, Curzio JL, Lees KR, Reid JL. White-coat hypertension as a cause of cardiovascular dysfunction. Lancet. 1996;348(9028): 654–657.
32. Cuspidi C, Sala C, Tadic M, Rescaldani M, Grassi G, Mancia G. Is white-coat hypertension a risk factor for carotid atherosclerosis? A review and meta-analysis. Blood Press Monit. 2015 Apr;20(2):57–63.
33. Cuspidi C, Rescaldani M, Tadic M, Sala C, Grassi G, Mancia G. White-coat hypertension, as defined by ambulatory blood pressure monitoring, and subclinical cardiac organ damage: a meta-analysis. J Hypertens. 2015;33(1):24–32.
34. Korhonen PE, Kivelä S-L, Kautiainen H, Järvenpää S, Kantola I. Health-related quality of life and awareness of hypertension. J Hypertens. 2011;29(11):2070–2074.
35. Lawrence WF, Fryback DG, Martin PA, Klein R, Klein BE. Health status and hypertension: a population-based study. J Clin Epidemiol. 1996;49(11):1239–1245.
36. Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol. 2004; 19(4):357–362.
37. Kjellgren KI, Ahlner J, Säljö R. Taking antihypertensive medication – controlling or co-operating with patients? Int J Cardiol. 1995;47(3):257–268.
38. Ong LM, de Haes JC, Hoos AM, Lammes FB. Doctor-patient communication: a review of the literature. Soc Sci Med. 1995;40(7):903–918.
39. Bensing JM, Dronkers J. Instrumental and affective aspects of physician behavior. Med Care. 1992;30(4):283–298.
40. Henry SG, Fuhrel-Forbis A, Rogers MA, Eggly S. Association between nonverbal communication during clinical interactions and outcomes: a systematic review and meta-analysis. Patient Educ Couns. 2012;86(3):297–315.
41. Stewart MA. What is a successful doctor-patient interview? A study of interactions and outcomes. Soc Sci Med. 1984;19(2):167–175.
42. Platt FW, Gaspar DL, Coulehan JL, et al. “Tell me about yourself”: the patient-centered interview. Ann Intern Med. 2001;134(11): 1079–1085.
43. Stewart M, Brown JB, Donner A, et al. The impact of patient-centered care on outcomes. J Fam Pract. 2000;49(9):796–804.
44. Williams S, Weinman J, Dale J. Doctor-patient communication and patient satisfaction: a review. Fam Pract. 1998;15(5):480–492.
45. Zolnierek KB, Dimatteo MR. Physician communication and patient adherence to treatment: a meta-analysis. Med Care. 2009;47(8): 826–834.
46. Stewart MA. Effective physician-patient communication and health outcomes: a review. CMAJ. 1995;152(9):1423–1433.
47. Kaplan SH, Greenfield S, Ware JE Jr. Assessing the effects of physician-patient interactions on the outcomes of chronic disease. Med Care. 1989;27(3)(Suppl):S110–S127.
48. Coulehan JL, Platt FW, Egener B, et al. “Let me see if i have this right …”: words that help build empathy. Ann Intern Med. 2001;135(3): 221–227.
49. Derksen F, Bensing J, Lagro-Janssen A. Effectiveness of empathy in general practice: a systematic review. Br J Gen Pract. 2013;63(606): e76–e84.
50. Fogarty LA, Curbow BA, Wingard JR, McDonnell K, Somerfield MR. Can 40 seconds of compassion reduce patient anxiety? J Clin Oncol. 1999;17(1):371–379.
51. Bonvicini KA, Perlin MJ, Bylund CL, Carroll G, Rouse RA, Goldstein MG. Impact of communication training on physician expression of empathy in patient encounters. Patient Educ Couns. 2009;75(1): 3–10.
52. Jenkins V, Fallowfield L. Can communication skills training alter physicians’ beliefs and behavior in clinics? J Clin Oncol. 2002;20(3): 765–769.
53. Fallowfield L, Jenkins V, Farewell V, Saul J, Duffy A, Eves R. Efficacy of a Cancer Research UK communication skills training model for oncologists: a randomised controlled trial. Lancet. 2002;359(9307):650–656.
54. Thom DH, Campbell B. Patient-physician trust: an exploratory study. J Fam Pract. 1997;44(2):169–176.
55. Tai-Seale M, McGuire TG, Zhang W. Time allocation in primary care office visits. Health Serv Res. 2007;42(5):1871–1894.
56. Haskard KB, Williams SL, DiMatteo MR, Rosenthal R, White MK, Goldstein MG. Physician and patient communication training in primary care: effects on participation and satisfaction. Health Psychol. 2008;27(5):513–522.
57. Rao JK, Anderson LA, Inui TS, Frankel RM. Communication interventions make a difference in conversations between physicians and patients: a systematic review of the evidence. Med Care. 2007;45(4): 340–349.
58. Cegala DJ, Lenzmeier Broz S. Physician communication skills training: a review of theoretical backgrounds, objectives and skills. Med Educ. 2002;36(11):1004–1016.
59. Levinson W, Lesser CS, Epstein RM. Developing physician communication skills for patient-centered care. Health Aff (Millwood). 2010;29(7):1310–1318.
60. Schoenthaler A, Kalet A, Nicholson J, Lipkin M. Does improving patient-practitioner communication improve clinical outcomes in patients with cardiovascular diseases? A systematic review of the evidence. Patient Educ Couns. 2014;96(1):3–12.
61. Roter DL, Hall JA, Kern DE, Barker LR, Cole KA, Roca RP. Improving physicians’ interviewing skills and reducing patients’ emotional distress. A randomized clinical trial. Arch Intern Med. 1995;155(17): 1877–1884.
62. Liénard A, Merckaert I, Libert Y, et al. Factors that influence cancer patients’ anxiety following a medical consultation: impact of a communication skills training programme for physicians. Ann Oncol. 2006;17(9):1450–1458.
63. Harrington J, Noble LM, Newman SP. Improving patients’ communication with doctors: a systematic review of intervention studies. Patient Educ Couns. 2004;52(1):7–16.
64. Thompson SC, Nanni C, Schwankovsky L. Patient-oriented interventions to improve communication in a medical office visit. Health Psychol. 1990;9(4):390–404.
65. Davison BJ, Degner LF. Empowerment of men newly diagnosed with prostate cancer. Cancer Nurs. 1997;20(3):187–196.
66. Cegala DJ, Marinelli T, Post D. The effects of patient communication skills training on compliance. Arch Fam Med. 2000;9(1):57–64.
67. Street RL Jr, Slee C, Kalauokalani DK, Dean DE, Tancredi DJ, Kravitz RL. Improving physician-patient communication about cancer pain with a tailored education-coaching intervention. Patient Educ Couns. 2010;80(1):42–47.
68. Kim YM, Putjuk F, Basuki E, Kols A. Increasing patient participation in reproductive health consultations: an evaluation of “Smart Patient” coaching in Indonesia. Patient Educ Couns. 2003;50(2):113–122.
69. Agha Z, Schapira RM, Laud PW, McNutt G, Roter DL. Patient satisfaction with physician-patient communication during telemedicine. Telemed J E Health. 2009;15(9):830–839.
70. Mair F, Whitten P. Systematic review of studies of patient satisfaction with telemedicine. BMJ. 2000;320(7248):1517–1520.
71. Rogers MA, Buchan DA, Small D, Stewart CM, Krenzer BE. Telemedicine improves diagnosis of essential hypertension compared with usual care. J Telemed Telecare. 2002;8(6):344–349.
72. Friedman RH, Kazis LE, Jette A, et al. A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. Am J Hypertens. 1996;9(4 Pt 1):285–292.
73. Laska KM, Gurman AS, Wampold BE. Expanding the lens of evidence-based practice in psychotherapy: a common factors perspective. Psychotherapy (Chic). 2014;51(4):467–481.